Medpace Holdings (MEDP) Gross Margin (2015 - 2026)

Medpace Holdings (MEDP) has 12 years of Gross Margin data on file, last reported at 28.51% in Q2 2026.

• Quarterly Gross Margin fell 133.0% year-over-year to 28.51% in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 28.76% (down 286.0% YoY) and the FY2025 annual result came in at 30.06%, down 106.0% from the prior year.
• Gross Margin climbed to 28.51% in Q2 2026, from 27.78% in the prior quarter.
• In the past five years, Gross Margin ranged from a high of 33.23% in Q4 2024 to a low of 26.97% in Q2 2023.
• A 5-year average of 29.51% and a median of 29.59% in 2022 frame the typical range for Gross Margin.
• Annual changes were most pronounced in 2024 — Gross Margin soared 578 bps — and 2025, when it tumbled 425 bps.
• Tracing MEDP's Gross Margin over 5 years: stood at 29.37% in 2022, then decreased by 7 bps to 27.45% in 2023, then gained by 21 bps to 33.23% in 2024, then declined by 13 bps to 28.98% in 2025, then declined by 2 bps to 28.51% in 2026.
• The last three Gross Margin figures came in at 28.51% (Q2 2026), 27.78% (Q1 2026), and 28.98% (Q4 2025), per Business Quant data.